Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation … – MarketWatch (press release)
Thursday, September 1st, 2011Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation ... MarketWatch (press release) 31, 2011 /PRNewswire via COMTEX/ -- Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase 2b clinical study to confirm the efficacy of its novel head lice treatment DeOvo(TM). This Phase 2b trial is evaluating the ... |